BackLantern Pharma Overview

Lantern Pharma Total Liabilities

Lantern Pharma's total liabilities is $3.8M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$3.78M
12.56% YoYΔ $-542484.00 vs prior year quarter

Peer average

Loading

Lantern Pharma Total Liabilities History

Loading

Lantern Pharma vs. peers: Total Liabilities Comparison

Loading

Lantern Pharma Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Lantern Pharma (LTRN) FAQ

As of the most recent data (March 2026), LTRN shows a total liabilities of $3.8M. That compares with $4.3M in the prior-year period — down 12.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LTRN's total liabilities is now $3.8M (was $4.3M) — a 12.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Lantern Pharma is outperforming or lagging.

Tracking LTRN's total liabilities over time shows whether Lantern Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $3.8M That compares with $4.3M in the prior-year period — down 12.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Lantern Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $3.8M) with ownership activity and broader fundamentals.

Lantern Pharma's total liabilities is $3.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.